兼收并蓄,博采众长——解读2016年欧洲抗风湿病联盟类风湿关节炎治疗建议

Interpretation of 2016 EULAR rheumatoid arthritis treatment recommendation

近年来类风湿关节炎(RA)的治疗药物及方法的临床研究不断增多,治疗理念不断更新,但临床上RA的缓解率仍然很低,对RA的用药方法和观念需要有更进一步的认识和提高。2016年欧洲抗风湿病联盟(EULAR)推出了新的RA治疗建议,较2013年版本有不少更新和补充。本文结合国内的RA治疗现状对此次EULAR会议上发布的RA治疗建议进行介绍和解读,拟为本病的临床治疗提供一定的参考。

In recent years, the treatment of rheumatoid arthritis （RA） concepts are updated continuously accompanied by an increase in clinical studies. However, the remission rate is still relatively low in clinical practice, and medication and concept of RA needs to he further understood and improved. In 2016 EUALR Congress, a new version of RA treatment recommendation has come up with many update and supplement comparing to 2013 version. Thus, the article provides an introduction and interpretation of the new version of RA treatment recommendation according to the domestic treatment status. The aim is to offer some references for RA treatment in clinic practice.